A cross-border outbreak of Salmonella Mbandaka ST413 has been ongoing in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) for over two years since September 2021.
This report presents the available data for describing the current situation regarding HIV prevalence among sex workers, and the efforts being made across Europe and Central Asia towards HIV prevention among this population.
From 1 January–24 October 2023, 335 laboratory-confirmed Salmonella Enteritidis ST11 cases belonging to three distinct microbiological clusters have been reported in 14 EU/EEA countries, the United Kingdom and the United States, affecting all age groups.
Since August 2022, cases of Salmonella Senftenberg have been identified in 13 countries worldwide. Case interviews suggest cherry-like tomatoes as a possible vehicle of infection.
Since June 2017, a cross-border outbreak of Salmonella Virchow ST16 has been ongoing in five EU/EEA countries, the UK, and the US. A total of 210 cases have been reported. No deaths have been reported. A majority of cases have been linked to local restaurants serving kebab meat.
Since the beginning of the outbreak declared on 20 September 2022 and as of 5 November 2022, Uganda has experienced 132 confirmed cases of Ebola disease (EBOD) caused by Sudan virus (SUDV), including 53 deaths and 61 recoveries across eight districts.
On 17 February 2022, the United Kingdom (UK) reported a cluster of cases with monophasic Salmonella Typhimurium sequence type 34 infection. As of 18 May 2022, 324 cases had been reported in 12 EU/EEA countries and the UK, including two distinct strains.
On 17 February 2022, the United Kingdom (UK) reported a cluster of cases with monophasic Salmonella Typhimurium sequence type 34 infection. By 8 April 2022, 150 cases had been reported in nine EU/EEA countries and the UK. Most cases are below 10 years of age and many children have been hospitalised.
This document assesses the risk of further spread of S. sonnei amongst MSM and in the broader population in EU/EEA countries, resulting from the current increase in extensively-drug resistant S. sonnei infections.